Today’s Market Runner: A Reversal for Edap Tms SA (ADR) Is Not Near. The Stock Declines Again

Today's Market Runner: A Reversal for Edap Tms SA (ADR) Is Not Near. The Stock Declines Again

The stock of Edap Tms SA (ADR) (NASDAQ:EDAP) is a huge mover today! About 97,841 shares traded hands or 17.02% up from the average. Edap Tms SA (ADR) (NASDAQ:EDAP) has declined 7.71% since April 18, 2016 and is downtrending. It has underperformed by 12.14% the S&P500.
The move comes after 7 months negative chart setup for the $95.39 million company. It was reported on Nov, 18 by We have $2.78 PT which if reached, will make NASDAQ:EDAP worth $10.49M less.

According to Zacks Investment Research, “EDAP TMS S.A. develops, produces, markets and distributes minimally invasive medical devices, primarily for the treatment of urological diseases. They currently produce and market devices for treatment of benign prostate hyperplasia and urinary tract stones. They are also developing a third range of products for minimally invasive destruction of certain types of tumors.”

More news for Edap Tms SA (ADR) (NASDAQ:EDAP) were recently published by:, which released: “DOW JONES, A NEWS CORP COMPANY” on February 11, 2011.‘s article titled: “Paris Terror Attacks Put French Stocks, ETF in Focus” and published on November 16, 2015 is yet another important article.

EDAP Company Profile

EDAP TMS S.A. (EDAP), incorporated on April 20, 1983, is a holding firm engaged in developing and marketing the Ablatherm and Focal One devices. The Firm operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). It offers products for HIFU treatment of localized prostate cancer. Through these two divisions, the Company develops, produces and markets medical devices, mainly for urological diseases. The Company’s HIFU and UDS divisions operate in Europe, the Americas, Asia and the rest of the world. The Firm is developing HIFU technology for the treatment of certain other types of tumors. The Firm also produces and commercializes medical equipment for treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL) and distributes other types of urology devices in certain countries.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment